Draw Group Ltd Focus serves as Executive at Yubo International Biotech Ltd, where they oversee executive responsibilities. Since joining the company, Draw Group Ltd Focus has executed 1 insider transactions totaling $2.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 23, 2022 involved selling 4,728,000 shares valued at $2.4M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 23, 2022 | YBGJ | $2.4M | Sale | 4,728,000 | $0.50 | Discretionary |
Draw Group Ltd Focus currently holds 9,101,400 shares of Yubo International Biotech Ltd (YBGJ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Draw Group Ltd Focus has been a net seller of YBGJ stock. They have purchased $0 and sold $2.4M worth of shares.
Draw Group Ltd Focus's most recent insider trade was on Sep 23, 2022, when they sold 4,728,000 shares at $0.50 per share.
Get notified when new Form 4 filings are submitted